Financials
Financial year 2025
Worth noting
- Little cash and receivables against the short-term debts.
Gross margin
€ 46,650
▲ 32% vs 2024
Profit
Growing€ 18,412
▲ 146% vs 2024
Debts
High€ 1.1 million
▼ 2% vs 2024
GENAPPE PHARMA INVEST from Genappe, company number BE0801925031, closed financial year 2025 with a result of € 18,412 after tax. For that financial year GENAPPE PHARMA INVEST recorded a gross margin of € 46,650 and equity of € 78,918. Compared with financial year 2024, the result moved from € 7,471 to € 18,412. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
What happened at GENAPPE PHARMA INVEST?
What happened at GENAPPE PHARMA INVEST in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 18,412 (▲ 146% vs 2024). Source: NBB ↗
- New establishment in Genappe. KBO
- Marie De Vriese became a director. NBB
- PHARMACIE DELVIGNE DOUMONT SA became a director. NBB
- RENAUD DOUMONT became a director. NBB
- PIERRE CLABOTS became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 3,035 profit in 2023 to € 18,412 profit in 2025.
Paid € 8,764 in corporate taxes since 2023.
Best year ever: 2025, with € 18,412 profit.
A new publication or filing at GENAPPE PHARMA INVEST? We notify you, reason included.
Follow GENAPPE PHARMA INVESTNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind GENAPPE PHARMA INVEST are Marie De Vriese, PHARMACIE DELVIGNE DOUMONT SA, RENAUD DOUMONT and PIERRE CLABOTS. It owns 100% of Pharmacie du Lothier itself.
Directors
According to the 2025 annual accounts
since 2023
Director · represented by RENAUD DOUMONT
since 2023
since 2023
since 2023
Establishments
Establishment units
Physical locations of this company
Rue de Charleroi 65 box Boite 1
1470 Genappe
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
Details
- Company number
- 0801.925.031
- VAT number
- BE 0801.925.031
- Registered office
- Rue de Charleroi 65 bus Boite 1, 1470 Genappe
- Names & denominations
- GENAPPE PHARMA INVEST · GPI
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 May 2023
- Peppol
- Active · Active since 12 Jun 2024
- Activities · NACE
Detailhandel in farmaceutische producten
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering